Smartphone Application to Support Mothers at Risk of Postpartum Depression
Effectiveness of a Smartphone Application for Mothers at High Risk for Postpartum Depression: A Randomized Controlled Trial
1 other identifier
interventional
79
1 country
1
Brief Summary
Effectiveness of a Smartphone Application for Mothers at High Risk for Postpartum Depression: A Randomized Controlled Trial Abstract Aim: This study aims to determine the effectiveness of a smartphone application in reducing symptoms of postpartum depression among Jordanian women. Background: Postpartum depression (PPD) is a serious mental health condition affecting an estimated 14-27% of mothers and negatively impacting infant health. Social support and certain psychological therapies have been shown to reduce depressive symptoms in postpartum women. Smartphone applications may provide a viable means of delivering psychological interventions to mothers experiencing such symptoms. Method: A randomized controlled trial will be conducted at two maternal and child health clinics in Irbid, Jordan. A total of 295 women will be invited to participate and will be asked to provide sociodemographic data and complete the Edinburgh Postnatal Depression Scale (EPDS) at 6-8 weeks (baseline) and again at 3 months postpartum. Women with a depressive symptom score of ≥13 (n ≈ 79) will be randomly assigned to either the intervention group (n ≈ 58) or the control group (n ≈ 57). The intervention will involve an Android smartphone application called Serene Motherhood, which will enable mothers to access evidence-based cognitive techniques and health information at any time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedFirst Submitted
Initial submission to the registry
August 30, 2025
CompletedFirst Posted
Study publicly available on registry
September 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2025
CompletedSeptember 11, 2025
September 1, 2025
3 months
August 30, 2025
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome is the symptoms of PPD measured by the Edinburgh Postnatal Depression Scale (EPDS)
The EPDS is a self-administered questionnaire consisting of ten items, with a total scoring range of 0 to 30 (Cox et al., 1987). Responses are rated on a 4-point scale (0, 1, 2, or 3) according to the severity of symptoms. Items 3, 5, and 10 are reverse-scored (i.e., 3, 2, 1, and 0). The total score is obtained by summing the scores for all ten items, after reversing the coding of negatively worded items, in accordance with the scoring guidelines to ensure consistency.
12 weeks per participant (from baseline assessment at 6-8 weeks postpartum to follow-up at 3 months postpartum)
Study Arms (2)
Intervention group
EXPERIMENTALThe intervention was an Android smartphone application called "Serene Motherhood," which enabled mothers to access evidence-based therapeutic cognitive techniques and health information at any time.
Control group
NO INTERVENTIONControl Group who received the routine care for postpartum mothers
Interventions
The Intervention: "Serene Motherhood" Application The "Serene Motherhood" application was a newly developed Android-based application created specifically for this study by the research team in collaboration with professional software developers. The content was adapted from authoritative guidelines provided by the American College of Obstetricians and Gynecologists (ACOG), the National Institute for Health and Care Excellence (NICE), the World Health Organization, and the American Psychological Association (APA, 2023; Mota \& Bø, 2021; NICE, 2016; WHO, 2022). The application was developed using the research project budget and was provided free of charge to all participants. The app aimed to integrate emotional and behavioral strategies, social support, and education for women with symptoms of PPD. The application combines evidence-based therapeutic techniques with user-friendly features supporting daily engagement with the app and self-management. Content and activities were grounded
Eligibility Criteria
You may qualify if:
- Jordanian women aged 18 to 45 years.
- Primigravida or multigravida
- Able to speak and read Arabic
- Between six and eight weeks postpartum
- EPDS score of ≥13
- Access to an Android-compatible smartphone
You may not qualify if:
- Complications during or after childbirth
- Newborn death or need for special/intensive care
- Positive response ("yes") to the suicidal ideation item on the EPDS (these participants will be referred to the Prince Basma Outpatient Clinics, Mental Health Department)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ibn Sina and Hawara Healthcare center
Irbid, 566, Jordan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 30, 2025
First Posted
September 11, 2025
Study Start
October 15, 2024
Primary Completion
January 15, 2025
Study Completion
September 12, 2025
Last Updated
September 11, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to the sensitive nature of personal and health information related to maternal mental health, which could compromise participant privacy and confidentiality. Only aggregated, de-identified results will be reported.